Atezolizumab in Combination With Nab-paclitaxel for Patients With Previously Untreated Metastatic Triple-negative Breast Cancer in a Real World Experience
Latest Information Update: 10 Nov 2022
At a glance
- Drugs Atezolizumab (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer; Triple negative breast cancer
- Focus Therapeutic Use
- Acronyms Anastase
- 02 Mar 2021 Results presented at the 19th International Congress on Targeted Anticancer Therapies
- 27 Jan 2021 New trial record
- 11 Dec 2020 Results presented at the 43rd Annual San Antonio Breast Cancer Symposium